Carol Dawn Berry, M.D.
Volunteer Assistant Clinical Professor, Division of Infectious Diseases, Department of Medicine
To see if Carol Dawn Berry is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
Philosophy of Care
The key to providing quality medical care is mindful listening and creating a trusting partnership.
Clinical Interests
Dr. Berry is an infection diseases specialist with clinical expertise with tuberculosis, including MDR-TB, HIV/AIDS, hantavirus, coccidioidomycosis, syphilis, malaria, wound care, antibiotic stewardship (ASP) and general infectious diseases issues.
Dr. Berry has enjoyed working with hospice, ICU, public health, home health and wound care nurses and with infectious diseases pharmacists on antibiotic stewardship rounds.
Research/Academic Interests
Dr. Berry has publications and presentations involving neurosyphilis, valley fever, malaria and enteric infection in HIV/AIDS. She has a special connection in caring for persons facing immunocompromise-associated challenges.
Division
Infectious Diseases
Undergraduate School
B.A., Goddard College, Plainfield VT 1974
Medical School
M.D., Albert Einstein College of Medicine, Bronx NY 1980
Other School
M.A., Cell Biology, Indiana University, Bloomington IN 1986
Internship
Internal Medicine, Cedars-Sinai Medical Center, Los Angeles CA 1980-1981
Residency
Internal Medicine, Cedars-Sinai Medical Center, Los Angeles CA 1980-1983
Fellowship
Internal Medicine, Division of Infectious Diseases, University of Washington, Seattle WA 1984-1987
Community Partner Award, California Tuberculosis Controllers Association, "for outstanding partnership and leadership in the care and control of TB in California", 2011,
Voted Top Doctor for Infectious Diseases in Sacramento, Sacramento Magazine, 2001,
Heroes in Healthcare Award, Coalition for Excellence in Healthcare, 1999,
Berry CD, Hooten TM, Collier AC, Lukehart, SA. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med. 1987; 316:1587-9.
White NJ, Miller KD, Marsh K, Berry CD, Turner RC, Williamson DH, Brown J. Hypoglycaemia in African children with severe malaria. Lancet. 1987; 1:708-11.
White NJ, Miller KD, Churchill FC, Berry CD, Brown J, Williams SB, Greenwood BM. Chloroquine treatment of severe malaria in children: Pharmacokinetics, toxicity, and new dosage recommendations. N Engl J Med. 1988; 319:1493-500.
Berry CD, Graham BS, Perez-Perez GI, Coombs RW, Montifiori, Chiang CS, Pandey JP, Grove TH, Ellison RT III, Blaser MJ. Anti-fusion and neutralizing activity, anti-CD4 and IgG allotypes in sera of HIV-infected patients. Thirty-First Interscience Conference on Antimicrobial Agents and Chemotherapy. 1991.
Berry CD, Blaser MJ, Johnson MA, Levin MT, Echeverrria P, Ellison RT III. Etiology of diarrheal disease in HIV-infected patients. Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy. 1991.
Blum RN, Berry CD, Phillips MG, Hamilos DL, Koneman EW. Clinical illnesses associated with isolation of dysgonic fermenter 3 from stool samples. J Clin Microbiol. 1992; 30:396-400.
Bessesen MT, Berry CD, Johnson MA, Klaus B, Blaser MJ, Ellison R III. Site of origin of disseminated MAC Infection in AIDS. Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy. 1990.
Berry CD, Ellison RT III, Johnson MA, Klaus BD, Levin MJ, Echeverria, Blaser MJ. Diarrheal disease in HIV-infected patients. Thirty-Third Interscience Conference on Antimicrobial Agents and Chemotherapy. 1993.
Waller D, Krishna S, Crawley J, Miller K, Nosten F, Chapman D, ter Kuile FO, Craddock C, Berry C, Holloway PA. Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis. 1995; 21:577-87.
Berry CD, Stevens DA, Hassid EI, Pappagianis D, Happs EL, Sahrakar K. A new method for the treatment of chronic fungal meningitis: continuous infusion into the cerebrospinal fluid for coccidioidal meningitis. Am J Med Sci. 2009; 338:79-82.